Introduction: The study aimed to evaluate the advantages of temporary inguinal ureterostomy in the management of neonates with uropathies and early or recurrent pyelonephritis. Patients and Methods: We performed a retrospective analysis of all patients who underwent ureterostomies between 1989 and 2012, with specific regards to indications and outcomes. We also performed a survey of parents to evaluate their acceptance of diversion. Results: We included 18 patients (12 primary high-grade vesicoureteral reflux [VUR] and 6 primary obstructive megaureters [MUs]). Indications were recurrent febrile urinary tract infections (UTIs) despite antibiotic prophylaxis, doubtful function of the overlying kidney for the oldest cases, when renal function was only assessed by intravenous urography, or both. Cutaneous diversion was performed between the ages of 2 weeks to 5 months (median: 1.8 months). Renal function was assessed prior to undiversion to choose between reimplantation and nephrectomy. The incidence of febrile UTIs significantly decreased during the period of diversion. Urinary diversion was judged socially acceptable by parents. Ureterostomy did not modify the overlying kidney function. Conclusion: Temporary inguinal ureterostomy does not enable better evaluation of renal function by suppressing the pressure of an obstacle or refluxing urines. Its remaining indication seems to be the prevention of recurrent UTIs in neonates and infants with VUR or MU, pending reimplantation.

Keywords:
Megaureter, Renal function, Neonate, Urinary tract infection, Vesicoureteral reflux , Ureterostomy
1.
Williams DI, Hulme-Moir I: Primary obstructive mega-ureter. Br J Urol 1970;42:140-149.
2.
Mallik M, Watson AR: Antenatally detected urinary tract abnormalities: more detection but less action. Pediatr Nephrol 2008;23:897-904.
3.
Shokeir AA, Nijman RJ: Primary megaureter: current trends in diagnosis and treatment. BJU Int 2000;86:861-868.
4.
Hemal AK, Ansari MS, Doddamani D, Gupta NP: Symptomatic and complicated adult and adolescent primary obstructive megaureter - indications for surgery: analysis, outcome, and follow-up. Urology 2003;61:703-707; discussion 707.
5.
Gimpel C, Masioniene L, Djakovic N, Schenk JP, Haberkorn U, Tonshoff B, Schaefer F: Complications and long-term outcome of primary obstructive megaureter in childhood. Pediatr Nephrol 2010;25:1679-1686.
6.
Trobs RB, Heinecke K, Elouahidi T, Nounla J, Kluge R: Renal function and urine drainage after conservative or operative treatment of primary (obstructive) megaureter in infants and children. Int Urol Nephrol 2006;38:141-147.
7.
Angerri O, Caffaratti J, Garat JM, Villavicencio H: Primary obstructive megaureter: initial experience with endoscopic dilatation. J Endourol 2007;21:999-1004.
8.
Christman MS, Kasturi S, Lambert SM, Kovell RC, Casale P: Endoscopic management and the role of double stenting for primary obstructive megaureters. J Urol 2012;187:1018-1023.
9.
Kajbafzadeh AM, Tourchi A: Concomitant endoureterotomy and dextranomer/hyaluronic acid subureteral injection for management of obstructive refluxing megaureter. J Endourol 2012;26:318-324.
10.
Lee SD, Akbal C, Kaefer M: Refluxing ureteral reimplant as temporary treatment of obstructive megaureter in neonate and infant. J Urol 2005;173:1357-1360; discussion 1360.
11.
Farrugia MK, Hitchcock R, Radford A, Burki T, Robb A, Murphy F: British Association of Paediatric Urologists consensus statement on the management of the primary obstructive megaureter. J Pediatr Urol 2014;10:26-33.
12.
Craig JC, Simpson JM, Williams GJ, et al: Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 2009;361:1748-1759.
13.
Walsh TJ, Hsieh S, Grady R, Mueller BA: Antenatal hydronephrosis and the risk of pyelonephritis hospitalization during the first year of life. Urology 2007;69:970-974.
14.
Rosen MA, Roth DR, Gonzales ET Jr: Current indications for cutaneous ureterostomy. Urology 1994;43:92-96.
15.
Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE: International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol 1985;15:105-109.
16.
Politano VA, Leadbetter WF: An operative technique for the correction of vesicoureteral reflux. J Urol 1958;79:932-941.
17.
Cain MP, Pope JC, Casale AJ, Adams MC, Keating MA, Rink RC: Natural history of refluxing distal ureteral stumps after nephrectomy and partial ureterectomy for vesicoureteral reflux. J Urol 1998;160(3 pt 2):1026-1027.
18.
Garcia-Aparicio L, Rodo J, Krauel L, Palazon P, Martin O, Ribo JM: High pressure balloon dilation of the ureterovesical junction - first line approach to treat primary obstructive megaureter? J Urol 2012;187:1834-1838.
19.
Farrugia MK, Steinbrecher HA, Malone PS: The utilization of stents in the management of primary obstructive megaureters requiring intervention before 1 year of age. J Pediatr Urol 2011;7:198-202.
20.
Lee YJ, Lee JH, Park YS: Risk factors for renal scar formation in infants with first episode of acute pyelonephritis: a prospective clinical study. J Urol 2012;187:1032-1036.
21.
Hinman F, Baskin L: Introduction to ureteroneocystosotomy; in Hinman F, Baskin L (eds): Hinman's Atlas of Pediatric Urologic Surgery, ed 2. Saunders Elsevier, 2009, pp 221-223.
22.
Mattioli G, Buffa P, Torre M, Carlini C, Pini Prato A, Castagnetti M, Betti E, Manzara A, Piaggio G, Perfumo F, Jasonni V: Urinary diversion in infants with primary high-grade vesicoureteric reflux, urinary sepsis and renal function impairment. Urol Int 2003;71:275-279.
23.
Kaefer M, Misseri R, Frank E, Rhee A, Lee SD: Refluxing ureteral reimplantation: a logical method for managing neonatal UVJ obstruction. J Pediatr Urol 2014;10:824-830.
24.
Sheldon CA, Gonzalez R, Mauer SM, Fraley EE: Obstructive uropathy, renal failure, and sepsis in the neonate - a surgical emergency. Urology 1980;16:457-463.
25.
Jagannath VA, Fedorowicz Z, Sud V, Verma AK, Hajebrahimi S: Routine neonatal circumcision for the prevention of urinary tract infections in infancy. Cochrane Database Syst Rev 2012;11:CD009129.
26.
Baum M: Postnatal developmental renal physiology: a study of historic significance. Am J Physiol Renal Physiol 2009;296:F667-F668.
27.
Othman S, Al-Hawas A, Al-Maqtari R: Renal cortical imaging in children: 99mTc MAG3 versus 99mTc DMSA. Clin Nucl Med 2012;37:351-355.
28.
Schlomer BJ, Smith PJ, Barber TD, Baker LA: Nephrectomy for hypertension in pediatric patients with a unilateral poorly functioning kidney: a contemporary cohort. J Pediatr Urol 2011;7:373-377.
29.
Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D: Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Pediatrics 2004;114:e469-e476.
30.
Cooper AC, Commers AR, Finkelstein M, Lipnik PG, Tollefson LM, Wilcox RA, Hoff DS: Otoacoustic emission screen results in critically ill neonates who received Gentamicin in the first week of life. Pharmacotherapy 2011;31:649-657.
31.
Risnes KR, Belanger K, Murk W, Bracken MB: Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am J Epidemiol 2011;173:310-318.
32.
de Lima Jacinto AK, Avelar AF, Pedreira ML: Predisposing factors for infiltration in children submitted to peripheral venous catheterization. J Infus Nurs 2011;34:391-398.
33.
Barreire SG, Oliveira OA, Kazama W, Kimura M, Santos VL: [Quality of life of children with stomas: the children and mothers' point of view]. J Pediatr (Rio J) 2003;79:55-62.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.